SHS stands for life science and medical technology investments.

For more than 25 years.

Our investment focus

From young companies to medium-sized businesses: We invest in fast-growing companies in the life science and medical technology sector.

Our portfolio

From cardiology to digital health: Our portfolio currently comprises more than 20 companies from the various life science and medical technology sub sectors.

Our investors

From pension funds to family offices: For many years partners have entrusted us with their capital in order to achieve attractive returns on it.

We are one of the leading life science & medical technology growth investors in Germany

SHS

Experience for more
than 25 years

Since its foundation in 1993, SHS has been involved in innovative companies in the fields of life science and medical technology.

We invest in young companies and also in established medium-sized companies.

Based on our long-standing sector experience, we contribute to partnerships not only our contacts with leading doctors, health insurance companies and industry experts, but also specialist expertise and an eye for long-term value-creating measures.

SHS in figures

0

Years of history

0

Fund generations

0

Transactions

0

Million €
current fund volume

0

Million €
AUM
(ca.)

0

Transactions assessments p.a.
(ca.)

Latest News

26 January 2021 - Newsletter

2020 – Uwe Steinbacher and Manfred Ulmer-Weber take stock for SHS

More

26 January 2021 - Newsletter

SHS invests in innovative specialist for drugs formulated specifically for delayed-release effects

More

26 January 2021 - Newsletter

Medtech specialist puracon GmbH sold to Klingel Medical Group

More